Dublin, July 18, 2025 (GLOBE NEWSWIRE) -- The "Germany Biotechnology Market Report and Forecast 2025-2034" has been added to ResearchAndMarkets.com's offering.
The Germany biotechnology market was valued at USD 35.30 Billion in 2024, bolstered by robust public and private investment in biotech innovation, alongside significant R&D endeavors supported by established academic and research institutions. The market is expected to grow at a CAGR of 10.30% during 2025-2034, potentially reaching USD 94.09 Billion by 2034.
Government initiatives and funding play a critical role in accelerating the development and commercialization of advanced biotechnological solutions, contributing to market expansion. This growth is also underpinned by strong infrastructure, substantial R&D capabilities, and a skilled workforce. The increasing adoption of precision medicine and biopharmaceuticals is anticipated to further drive market growth in the forecast period.
Increasing Prevalence of Chronic Diseases
The market's growth is heavily influenced by the rising incidence of chronic and degenerative diseases. According to WHO data from 2021, conditions such as ischemic heart disease, Alzheimer's disease, stroke, various cancers, COPD, and kidney disorders impose a significant health burden, intensifying demand for innovative diagnostics, targeted therapies, and precision medicine. This drives forward the biotechnology sector, bolstered by increased research and development investments from both public and private sectors.
Germany Biotechnology Market Trends
Key trends include rising investments and the advent of cutting-edge, sustainable technologies. Investment confidence continues to grow, evidenced by a 78% increase in funding for German biotech firms, reaching EUR 1.917 billion in 2024, according to BIO Deutschland and EY. This capital influx is set to enhance market growth and technological progress.
Additionally, innovative, eco-friendly food technologies are driving demand. In March 2024, the launch of Kynda's zero-waste mycelium-based food product in Germany highlighted a move towards sustainable consumer solutions, anticipating an increase in the market's growth and the adoption of sustainable biotech products.
Germany Biotechnology Market Segmentation
The market analysis includes segments such as:
- Product Type: Instruments, Reagents, Software and Services, Others
- Technology: Nanobiotechnology, Tissue Engineering, DNA Sequencing, Cell-based Assays, Fermentation, PCR Technology, Chromatography, Others
- Application: Health, Food & Agriculture, Natural Resources & Environment, Industrial Processing, Bioinformatics, Others
Germany Biotechnology Market Share: DNA Sequencing's Impact
The biotechnology market in Germany is diversified across various technologies, with DNA sequencing anticipated to lead. Innovations like Merck's Aptegra platform, which integrates multiple assays into one, significantly reduce testing times and costs, driving DNA sequencing's important role in the market's future growth.
Leading Players in the Germany Biotechnology Market
The major market players include:
- QIAGEN N.V: Expanded its portfolio by acquiring Genoox, enhancing AI-driven genetic data interpretation for clinical decision-making.
- Thermo Fisher Scientific, Inc: Introduced sustainable centrifuges in Germany, boosting energy efficiency in bioprocessing.
- Illumina Inc: Partnered with Ovation.io to launch an extensive clinical multiomic dataset, propelling advancements in metabolic disease therapies.
- F. Hoffman-La Roche Ltd: Gained FDA clearance for a dual mRNA probe assay improving B-cell lymphoma diagnostics.
Other key companies include Evotec SE, Bio-Rad Laboratories, Agilent Technologies, and BioNTech SE.
Key Questions Answered
- What was the Germany biotechnology market value in 2024?
- What is the forecast for 2025-2034?
- What drives demand in the market?
- How has the market performed historically, and future expectations?
- What are the major trends and challenges?
- Which product, technology, and application segments are expected to dominate?
- Who are the key players?
Key Attributes
| Report Attribute | Details |
| No. of Pages | 250 |
| Forecast Period | 2025-2034 |
| Estimated Market Value (USD) in 2025 | $35.3 Billion |
| Forecasted Market Value (USD) by 2034 | $94.09 Billion |
| Compound Annual Growth Rate | 10.3% |
| Regions Covered | Germany |
Key Topics Covered
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage - Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Biotechnology Market Overview
- 3.1 Europe Biotechnology Market
- 3.2 Germany Biotechnology Market
- 4 Vendor Positioning Analysis
- 4.1 Key Vendors
- 4.2 Prospective Leaders
- 4.3 Niche Leaders
- 4.4 Disruptors
- 5 Germany Biotechnology Market Landscape
- 5.1 Germany Biotechnology Market: Developers Landscape
- 5.2 Germany Biotechnology Market: Product Landscape
- 6 Germany Biotechnology Market Dynamics
- 6.1 Market Drivers and Constraints
- 6.2 SWOT Analysis
- 6.3 PESTEL Analysis
- 6.4 Porter's Five Forces Model
- 6.5 Key Demand Indicators
- 6.6 Key Price Indicators
- 6.7 Industry Events, Initiatives, and Trends
- 6.8 Value Chain Analysis
- 7 Germany Biotechnology Market Segmentation (2018-2034)
- 7.1 By Product Type
- 7.2 By Technology
- 7.3 By Application
- 8 Regulatory Framework
- 9 Patent Analysis
- 10 Funding and Investment Analysis
- 11 Strategic Initiatives
- 12 Supplier Landscape
- 13 Germany Biotechnology Market - Distribution Model (Additional Insight)
- 14 Key Opinion Leaders (KOL) Insights (Additional Insight)
For more information about this report visit https://www.researchandmarkets.com/r/2dvmnn
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
